Elicio Therapeutics appoints Preetam Shah as chief strategy, financial officer

Elicio Therapeutics (ELTX) announced the appointment of Preetam Shah, Ph.D., MBA, as Chief Strategy and Financial Officer, effective as of the date hereof. Prior to joining Elicio, Dr. Shah served as the CFO and CBO of Cidara Therapeutics (CDTX).